Logo image of ONTEX.BR

ONTEX GROUP NV (ONTEX.BR) Stock Fundamental Analysis

EBR:ONTEX - Euronext Brussels - BE0974276082 - Common Stock - Currency: EUR

7.74  +0.07 (+0.91%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ONTEX. ONTEX was compared to 12 industry peers in the Personal Care Products industry. ONTEX may be in some trouble as it scores bad on both profitability and health. ONTEX has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ONTEX was profitable.
In the past year ONTEX had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ONTEX reported negative net income in multiple years.
ONTEX had a positive operating cash flow in each of the past 5 years.
ONTEX.BR Yearly Net Income VS EBIT VS OCF VS FCFONTEX.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

The Return On Assets of ONTEX (0.44%) is worse than 75.00% of its industry peers.
Looking at the Return On Equity, with a value of 1.11%, ONTEX is doing worse than 75.00% of the companies in the same industry.
The Return On Invested Capital of ONTEX (6.78%) is worse than 75.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ONTEX is significantly below the industry average of 12.75%.
The last Return On Invested Capital (6.78%) for ONTEX is above the 3 year average (4.39%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.44%
ROE 1.11%
ROIC 6.78%
ROA(3y)-2.71%
ROA(5y)-1.72%
ROE(3y)-8.84%
ROE(5y)-5.5%
ROIC(3y)4.39%
ROIC(5y)4.43%
ONTEX.BR Yearly ROA, ROE, ROICONTEX.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

ONTEX has a worse Profit Margin (0.55%) than 75.00% of its industry peers.
In the last couple of years the Profit Margin of ONTEX has declined.
ONTEX's Operating Margin of 7.98% is on the low side compared to the rest of the industry. ONTEX is outperformed by 75.00% of its industry peers.
In the last couple of years the Operating Margin of ONTEX has grown nicely.
With a Gross Margin value of 29.23%, ONTEX is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
ONTEX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.98%
PM (TTM) 0.55%
GM 29.23%
OM growth 3Y8.65%
OM growth 5Y4.46%
PM growth 3YN/A
PM growth 5Y-19.47%
GM growth 3Y0.83%
GM growth 5Y1.47%
ONTEX.BR Yearly Profit, Operating, Gross MarginsONTEX.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

3

2. Health

2.1 Basic Checks

ONTEX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, ONTEX has about the same amount of shares outstanding.
ONTEX has more shares outstanding than it did 5 years ago.
ONTEX has a better debt/assets ratio than last year.
ONTEX.BR Yearly Shares OutstandingONTEX.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ONTEX.BR Yearly Total Debt VS Total AssetsONTEX.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 1.33, we must say that ONTEX is in the distress zone and has some risk of bankruptcy.
ONTEX's Altman-Z score of 1.33 is on the low side compared to the rest of the industry. ONTEX is outperformed by 83.33% of its industry peers.
The Debt to FCF ratio of ONTEX is 6.97, which is on the high side as it means it would take ONTEX, 6.97 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 6.97, ONTEX is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
ONTEX has a Debt/Equity ratio of 0.72. This is a neutral value indicating ONTEX is somewhat dependend on debt financing.
ONTEX's Debt to Equity ratio of 0.72 is in line compared to the rest of the industry. ONTEX outperforms 41.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 6.97
Altman-Z 1.33
ROIC/WACC1.14
WACC5.95%
ONTEX.BR Yearly LT Debt VS Equity VS FCFONTEX.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

ONTEX has a Current Ratio of 1.21. This is a normal value and indicates that ONTEX is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ONTEX (1.21) is comparable to the rest of the industry.
A Quick Ratio of 0.81 indicates that ONTEX may have some problems paying its short term obligations.
ONTEX has a Quick ratio of 0.81. This is in the better half of the industry: ONTEX outperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.81
ONTEX.BR Yearly Current Assets VS Current LiabilitesONTEX.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

ONTEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -72.09%.
The earnings per share for ONTEX have been decreasing by -23.62% on average. This is quite bad
The Revenue has been growing slightly by 3.67% in the past year.
Measured over the past years, ONTEX shows a decrease in Revenue. The Revenue has been decreasing by -4.00% on average per year.
EPS 1Y (TTM)-72.09%
EPS 3YN/A
EPS 5Y-23.62%
EPS Q2Q%-71.21%
Revenue 1Y (TTM)3.67%
Revenue growth 3Y9.72%
Revenue growth 5Y-4%
Sales Q2Q%4.6%

3.2 Future

The Earnings Per Share is expected to grow by 11.39% on average over the next years. This is quite good.
ONTEX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.66% yearly.
EPS Next Y11.67%
EPS Next 2Y10.35%
EPS Next 3Y11.39%
EPS Next 5YN/A
Revenue Next Year3.29%
Revenue Next 2Y3.44%
Revenue Next 3Y3.66%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ONTEX.BR Yearly Revenue VS EstimatesONTEX.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
ONTEX.BR Yearly EPS VS EstimatesONTEX.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 64.50, which means the current valuation is very expensive for ONTEX.
Based on the Price/Earnings ratio, ONTEX is valued expensively inside the industry as 83.33% of the companies are valued cheaper.
Compared to an average S&P500 Price/Earnings ratio of 26.43, ONTEX is valued quite expensively.
ONTEX is valuated cheaply with a Price/Forward Earnings ratio of 6.34.
100.00% of the companies in the same industry are more expensive than ONTEX, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.17. ONTEX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 64.5
Fwd PE 6.34
ONTEX.BR Price Earnings VS Forward Price EarningsONTEX.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ONTEX is valued cheaper than 83.33% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ONTEX is valued cheaply inside the industry as 91.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.17
EV/EBITDA 5.82
ONTEX.BR Per share dataONTEX.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ONTEX does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)5.52
PEG (5Y)N/A
EPS Next 2Y10.35%
EPS Next 3Y11.39%

0

5. Dividend

5.1 Amount

No dividends for ONTEX!.
Industry RankSector Rank
Dividend Yield N/A

ONTEX GROUP NV

EBR:ONTEX (6/4/2025, 7:00:00 PM)

7.74

+0.07 (+0.91%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)04-30 2025-04-30
Earnings (Next)07-31 2025-07-31
Inst Owners40.92%
Inst Owner ChangeN/A
Ins Owners3.06%
Ins Owner ChangeN/A
Market Cap637.39M
Analysts81.43
Price Target11.26 (45.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.71%
PT rev (3m)1.84%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-4.34%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.45%
Revenue NY rev (3m)-1%
Valuation
Industry RankSector Rank
PE 64.5
Fwd PE 6.34
P/S 0.34
P/FCF 6.17
P/OCF 2.95
P/B 0.69
P/tB 6.89
EV/EBITDA 5.82
EPS(TTM)0.12
EY1.55%
EPS(NY)1.22
Fwd EY15.78%
FCF(TTM)1.25
FCFY16.21%
OCF(TTM)2.62
OCFY33.84%
SpS22.59
BVpS11.24
TBVpS1.12
PEG (NY)5.52
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.44%
ROE 1.11%
ROCE 9.14%
ROIC 6.78%
ROICexc 7.02%
ROICexgc 15%
OM 7.98%
PM (TTM) 0.55%
GM 29.23%
FCFM 5.55%
ROA(3y)-2.71%
ROA(5y)-1.72%
ROE(3y)-8.84%
ROE(5y)-5.5%
ROIC(3y)4.39%
ROIC(5y)4.43%
ROICexc(3y)4.61%
ROICexc(5y)4.96%
ROICexgc(3y)9.94%
ROICexgc(5y)12.9%
ROCE(3y)5.92%
ROCE(5y)5.98%
ROICexcg growth 3Y14.1%
ROICexcg growth 5Y2.75%
ROICexc growth 3Y23.18%
ROICexc growth 5Y5.84%
OM growth 3Y8.65%
OM growth 5Y4.46%
PM growth 3YN/A
PM growth 5Y-19.47%
GM growth 3Y0.83%
GM growth 5Y1.47%
F-Score6
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 6.97
Debt/EBITDA 3
Cap/Depr 151.69%
Cap/Sales 6.04%
Interest Coverage 3.95
Cash Conversion 96.9%
Profit Quality 1002.91%
Current Ratio 1.21
Quick Ratio 0.81
Altman-Z 1.33
F-Score6
WACC5.95%
ROIC/WACC1.14
Cap/Depr(3y)125.61%
Cap/Depr(5y)112.58%
Cap/Sales(3y)5.05%
Cap/Sales(5y)4.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.09%
EPS 3YN/A
EPS 5Y-23.62%
EPS Q2Q%-71.21%
EPS Next Y11.67%
EPS Next 2Y10.35%
EPS Next 3Y11.39%
EPS Next 5YN/A
Revenue 1Y (TTM)3.67%
Revenue growth 3Y9.72%
Revenue growth 5Y-4%
Sales Q2Q%4.6%
Revenue Next Year3.29%
Revenue Next 2Y3.44%
Revenue Next 3Y3.66%
Revenue Next 5YN/A
EBIT growth 1Y43.9%
EBIT growth 3Y19.21%
EBIT growth 5Y0.28%
EBIT Next Year94.21%
EBIT Next 3Y29.88%
EBIT Next 5YN/A
FCF growth 1Y61.15%
FCF growth 3Y11.86%
FCF growth 5Y-5.23%
OCF growth 1Y34.31%
OCF growth 3Y18.3%
OCF growth 5Y-2.03%